Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-23-002340 General Corporate
Debt relative to revenue 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
146.11% · OPTIONAL · VALID
Capex intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.63% · OPTIONAL · VALID
Operating cash generation 40th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
5.39% · OPTIONAL · VALID
Revenue growth 29th Own-history percentile · N=17
Evidence method Yoy · gp.fundamentals.revenue
-0.31% · CORE · VALID
Inventory pressure 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
72.95% · OPTIONAL · VALID
Gross margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
18.76% · CORE · VALID
Operating margin 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
10.88% · CORE · VALID
R&D intensity 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.35% · OPTIONAL · VALID
SBC intensity 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.62% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 24.90%
Current 146.11%
Delta 121.21% Capex Intensity Decreased
Previous 4.88%
Current 3.63%
Delta -1.26% Cash Generation Increased
Previous 2.31%
Current 5.39%
Delta 3.07% Growth Decreased
Previous 26.75%
Current -0.31%
Delta -27.06% Inventory Pressure Increased
Previous 15.37%
Current 72.95%
Delta 57.59% Margin Decreased
Previous 20.48%
Current 18.76%
Delta -1.72% Profitability Increased
Previous 9.00%
Current 10.88%
Delta 1.88% R And D Intensity Increased
Previous 1.27%
Current 1.35%
Delta 0.07% Sbc Intensity Increased
Previous 0.53%
Current 0.62%
Delta 0.09% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.